The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Aballi John since 2022.
This trader's CIK number is 1843113.
At the time of last reporting, Aballi John was the President and CEO of Exagen Inc.. (stock ticker symbol XGN).
Also see all insider trading activities at Exagen Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | XGN | 64,706 | $145,866 | 0 | $0 | 0 | $0 |
| 2022 | XGN | 90,000 | $241,200 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-14 | XGN | Buy | 24,305 | 2.81 | 68,297 |
| 2024-05-16 | XGN | Buy | 40,401 | 1.92 | 77,569 |
| 2022-12-08 | XGN | Buy | 90,000 | 2.68 | 241,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aballi John (President and CEO of Exagen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.